MCID: NRV004
MIFTS: 39

Nerve Compression Syndrome

Categories: Neuronal diseases

Aliases & Classifications for Nerve Compression Syndrome

MalaCards integrated aliases for Nerve Compression Syndrome:

Name: Nerve Compression Syndrome 12 15 17 74
Entrapment Neuropathies 56 74
Hereditary Liability to Pressure Palsies 74
Peripheral Nerve Entrapment Syndrome 12
Nerve Compression Syndromes 45
Compression Neuropathy 12
Entrapment Neuropathy 12

Classifications:



External Ids:

Disease Ontology 12 DOID:573
MeSH 45 D009408
NCIt 51 C27221
SNOMED-CT 69 45781009

Summaries for Nerve Compression Syndrome

MalaCards based summary : Nerve Compression Syndrome, also known as entrapment neuropathies, is related to tarsal tunnel syndrome and al amyloidosis, and has symptoms including neuralgia An important gene associated with Nerve Compression Syndrome is B2M (Beta-2-Microglobulin). The drugs Lidocaine and Bupivacaine have been mentioned in the context of this disorder. Affiliated tissues include testes, skin and spinal cord.

Wikipedia : 77 Nerve compression syndrome or compression neuropathy, also known as entrapment neuropathy, is a medical... more...

Related Diseases for Nerve Compression Syndrome

Diseases related to Nerve Compression Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 92)
# Related Disease Score Top Affiliating Genes
1 tarsal tunnel syndrome 32.2 B2M NOTCH1 TTR
2 al amyloidosis 29.9 B2M TTR
3 peripheral nervous system disease 29.7 ARHGEF10 PSMD9 TTR
4 carpal tunnel syndrome 29.5 B2M COL5A1 PSMD9 TTR
5 neuropathy, hereditary, with liability to pressure palsies 11.2
6 osteopetrosis, autosomal dominant 2 11.0
7 osteopetrosis, autosomal recessive 1 11.0
8 osteopetrosis, autosomal recessive 2 11.0
9 osteopetrosis, autosomal recessive 5 11.0
10 osteopetrosis, autosomal recessive 3 11.0
11 osteopetrosis, autosomal dominant 1 11.0
12 osteopetrosis, autosomal recessive 4 11.0
13 osteopetrosis, autosomal recessive 6 11.0
14 osteopetrosis, autosomal recessive 7 11.0
15 osteopetrosis 11.0
16 uremic neuropathy 10.2 ARHGEF10 B2M
17 median rhomboid glossitis 10.2 B2M TTR
18 amyloid tumor 10.2 B2M TTR
19 hereditary amyloidosis 10.2 B2M TTR
20 amyloidosis aa 10.1 B2M TTR
21 tibial neuropathy 10.1 B2M NOTCH1 TTR
22 retinitis pigmentosa 7 10.1 B2M TTR
23 amyloidosis, familial visceral 10.0 B2M TTR
24 radiculopathy 10.0
25 meralgia paresthetica 10.0
26 osteochondroma 10.0
27 inguinal hernia 9.9
28 gilles de la tourette syndrome 9.8
29 popliteal cyst 9.8
30 neuritis 9.8
31 neuroma 9.8
32 tenosynovitis 9.8
33 amyotrophic lateral sclerosis 1 9.8
34 charcot-marie-tooth disease, demyelinating, type 1b 9.8
35 parkinson disease, late-onset 9.8
36 rheumatoid arthritis 9.8
37 muscle hypertrophy 9.8
38 arthritis 9.8
39 cerebral palsy 9.8
40 charcot-marie-tooth disease 9.8
41 diabetes mellitus 9.8
42 diabetic neuropathy 9.8
43 intermittent claudication 9.8
44 multifocal motor neuropathy 9.8
45 spastic cerebral palsy 9.8
46 focal hand dystonia 9.8
47 tooth disease 9.8
48 mononeuropathy 9.8
49 ulnar nerve lesion 9.8
50 hypermobility syndrome 9.8

Graphical network of the top 20 diseases related to Nerve Compression Syndrome:



Diseases related to Nerve Compression Syndrome

Symptoms & Phenotypes for Nerve Compression Syndrome

UMLS symptoms related to Nerve Compression Syndrome:


neuralgia

Drugs & Therapeutics for Nerve Compression Syndrome

Drugs for Nerve Compression Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 232)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 137-58-6 3676
2
Bupivacaine Approved, Investigational Phase 4,Phase 1,Not Applicable,Early Phase 1 2180-92-9, 38396-39-3 2474
3
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 302-25-0
4
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 50-24-8 5755
5
Methylprednisolone hemisuccinate Approved Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 2921-57-5
6
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 83-43-2 6741
7
Epinephrine Approved, Vet_approved Phase 4,Not Applicable 51-43-4 5816
8
Racepinephrine Approved Phase 4,Not Applicable 329-65-7 838
9
Triamcinolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 124-94-7 31307
10
Acetaminophen Approved Phase 4,Phase 2 103-90-2 1983
11
Ketorolac Approved Phase 4 66635-83-4, 74103-06-3 3826
12
Gabapentin Approved, Investigational Phase 4,Phase 3 60142-96-3 3446
13
Ropivacaine Approved Phase 4,Not Applicable 84057-95-4 71273 175805
14
Betamethasone Approved, Vet_approved Phase 4,Phase 3 378-44-9 9782
15
Oxycodone Approved, Illicit, Investigational Phase 4,Phase 2 76-42-6 5284603
16
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
17
Ibuprofen Approved Phase 4,Phase 2 15687-27-1 3672
18
Hydrocodone Approved, Illicit, Investigational Phase 4 125-29-1 5284569
19
tannic acid Approved Phase 4,Not Applicable 1401-55-4
20
Benzocaine Approved, Investigational Phase 4,Not Applicable 94-09-7, 1994-09-7 2337
21
Cefazolin Approved Phase 4 25953-19-9 656510 33255
22
Vancomycin Approved Phase 4 1404-90-6 441141 14969
23
Nimodipine Approved, Investigational Phase 4 66085-59-4 4497
24
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 59-30-3 6037
25
Vitamin A Approved, Nutraceutical, Vet_approved Phase 4 22737-96-8, 68-26-8, 11103-57-4 9904001 445354
26
Prednisolone hemisuccinate Experimental Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 2920-86-7
27 Protective Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
28 Diuretics, Potassium Sparing Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
29 Anesthetics Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
30 Anesthetics, Local Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
31 Anti-Arrhythmia Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
32 Sodium Channel Blockers Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
33 Central Nervous System Depressants Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
34 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
35 Anti-Inflammatory Agents Phase 4,Phase 2,Phase 3,Not Applicable
36 Prednisolone acetate Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
37 Autonomic Agents Phase 4,Phase 2,Phase 3,Not Applicable
38 Hormones Phase 4,Phase 2,Phase 3,Not Applicable
39 Neuroprotective Agents Phase 4,Phase 2,Phase 3,Not Applicable
40 glucocorticoids Phase 4,Phase 2,Phase 3,Not Applicable
41 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2,Phase 3,Not Applicable
42 Gastrointestinal Agents Phase 4,Phase 2,Phase 3,Not Applicable
43 Antiemetics Phase 4,Phase 2,Phase 3,Not Applicable
44 Methylprednisolone Acetate Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
45 Antineoplastic Agents, Hormonal Phase 4,Phase 2,Phase 3,Not Applicable
46 Hormone Antagonists Phase 4,Phase 2,Phase 3,Not Applicable
47 Analgesics Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
48 Analgesics, Non-Narcotic Phase 4,Phase 2,Not Applicable
49 Antimanic Agents Phase 4,Phase 3,Not Applicable
50 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 309)
# Name Status NCT ID Phase Drugs
1 Postoperative Alpha Lipoic Acid in the Carpal Tunnel Syndrome: a Randomized Controlled Trial. Completed NCT01895621 Phase 4
2 Onset and Duration of Forearm Nerve Blockade Completed NCT03649763 Phase 4 Lidocaine;Bupivacaine;Lidocaine
3 Myofascial Release on Electrophysiological Measures of Pregnant Women With CTS Completed NCT03802448 Phase 4
4 Local Steroid Injection vs Placebo in Carpal Tunnel Syndrome Completed NCT02652390 Phase 4 Methylprednisolone 80 mg;Methylprednisolone 40 mg
5 Pain Outcomes of Intra-operative IV Tylenol and/or IV Toradol for Carpal Tunnel and Distal Radius Fracture Surgeries Completed NCT02313675 Phase 4 Acetaminophen;Ketorolac Tromethamine;Saline
6 Efficacy Study of Local Steroid Injection and Wrist Splinting for Carpal Tunnel Syndrome Completed NCT02140632 Phase 4
7 Bupivacaine Versus Lidocaine Local Anesthesia Completed NCT01751347 Phase 4 Bupivacaine;Lidocaine
8 Length of Post Operative Dressing After Carpal Tunnel Release Completed NCT01310218 Phase 4
9 A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions Completed NCT00904202 Phase 4 Placebo Capsules + Placebo Patch;Placebo capsules + Lidoderm®;Gabapentin + Placebo;Gabapentin + Lidoderm®;Gabapentin 300 mg capsules 1800 mg/day + placebo patch;Gabapentin 1800 mg/day + Lidoderm patch
10 Patient Controlled Regional Analgesia Following Carpal Tunnel Release: A Double-Blind Study Using Distal Perineural Catheters Completed NCT00678314 Phase 4 Ropivacaine 0.2%;Ropivacaine 0.75%;Normal saline
11 Therapeutic Effects Analysis of Pudendal Nerve Infiltrations After 3 Months, in Patients Suffering of Pudendal Neuralgia Completed NCT00851513 Phase 4 Lidocaine;Depmedrol
12 Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome Completed NCT00277563 Phase 4
13 Exparel and Education to Avoid Opioids After Carpal Tunnel Release Recruiting NCT03867539 Phase 4
14 Narcotic vs. Non-narcotic Pain Study Protocol Recruiting NCT01974609 Phase 4 Narcotic;non-narcotic
15 Non-surgical Treatment of Carpal Tunnel Syndrome: Night Splint Versus Local Corticosteroid Infiltration Active, not recruiting NCT03196817 Phase 4 betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2%
16 Injection Versus Splinting in Carpal Tunnel Syndrome Active, not recruiting NCT02038452 Phase 4 Depo-Medrone
17 Preoperative Antibiotics for Carpal Tunnel Release Surgery Not yet recruiting NCT03432858 Phase 4 Vancomycin;Cefazolin;Saline Solution
18 Comparison of the Efficacy of Corticosteroid Injection and ESWT in Patients With CTS Not yet recruiting NCT03792945 Phase 4 local injection
19 Post-operative Analgesia in Elective, Soft-tissue Hand Surgery Terminated NCT02029235 Phase 4 Acetaminophen/Ibuprofen;Acetaminophen/Hydrocodone
20 Patient Satisfaction With Pain Relief After Ambulatory Hand Surgery Terminated NCT01588158 Phase 4 Acetaminophen;Vicodin
21 Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain Withdrawn NCT02748395 Phase 4 Triamcinolone;Lidocaine
22 Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A) Unknown status NCT01289704 Phase 2, Phase 3
23 Assessment of the Effectiveness of Ultrasound-guided Acupuncture in the Management of Carpal Tunnel Syndrome Unknown status NCT02870673 Phase 2, Phase 3 SHINCORT;XYLOCAINE
24 Carpal Tunnel Syndrome Release Using PSU Retractor Unknown status NCT01017471 Phase 3
25 Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) Completed NCT02579759 Phase 3 PXT3003 dose 1;PXT3003 dose 2;placebo
26 High Dose Ascorbic Acid Treatment of CMT1A Completed NCT00484510 Phase 2, Phase 3 Ascorbic acid (Vitamin C);placebo
27 Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome Completed NCT02141035 Phase 2, Phase 3 Acetyl-l-carnitine;placebo
28 Sonographic Examination Cubital Tunnel Release Completed NCT02739945 Phase 3
29 Sonography-guided Steroid Injection for Carpal Tunnel Syndrome Completed NCT02575729 Phase 3 betamethasone
30 Preoperative Gabapentine for Carpal Tunnel Completed NCT01632215 Phase 3 Gabapentine
31 Steroid Injection Treatment of Carpal Tunnel Syndrome Completed NCT00806871 Phase 2, Phase 3 Methylprednisolone 40 mg;Methylprednisolone 80 mg;Sodium chloride
32 Gabapentin for Carpal Tunnel Syndrome Completed NCT00137735 Phase 3 Gabapentin
33 Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia Completed NCT02604186 Phase 2, Phase 3
34 Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid Completed NCT00007020 Phase 3 Cholic Acids
35 Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Recruiting NCT03023540 Phase 3 PXT3003
36 Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Patients With Moderate to Severe Obesity Recruiting NCT03746522 Phase 3 Setmelanotide;Placebos
37 Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity Recruiting NCT03013543 Phase 2, Phase 3 Setmelanotide
38 Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome Enrolling by invitation NCT03184584 Phase 2, Phase 3 PBI-4050
39 Erythropoietin Spinal Cord Compression Randomized Trial Terminated NCT00220675 Phase 2, Phase 3 Erythropoietin infusion
40 NeuroPath Comparative Validation Study Plan Terminated NCT00393549 Phase 3
41 A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures Terminated NCT00209560 Phase 3 fospropofol disodium
42 Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome Terminated NCT00266214 Phase 3 lidocaine patch 5%
43 SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study Unknown status NCT02967679 Phase 1, Phase 2 MD1003
44 Carpal Tunnel Syndrome and Static Magnetic Field Therapy Unknown status NCT00521495 Phase 2
45 Carpal Tunnel Syndrome Treated With 830nm Diode Laser Unknown status NCT00514462 Phase 1, Phase 2
46 Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease Completed NCT00541164 Phase 1, Phase 2 Coenzyme Q10
47 Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease Completed NCT02561702 Phase 2 Mexiletine
48 Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A Completed NCT01401257 Phase 2 PXT3003 Low dose;PXT3003 Intermediate Dose;PXT3003 High Dose
49 Ascorbic Acid Treatment in CMT1A Trial (AATIC) Completed NCT00271635 Phase 2 Placebo;ascorbic acid
50 The Treatment of the Median Nerve for the Elimination of the Symptoms Associated With the Carpal Tunnel Syndrome Completed NCT00634738 Phase 1, Phase 2

Search NIH Clinical Center for Nerve Compression Syndrome

Cochrane evidence based reviews: nerve compression syndromes

Genetic Tests for Nerve Compression Syndrome

Anatomical Context for Nerve Compression Syndrome

MalaCards organs/tissues related to Nerve Compression Syndrome:

42
Testes, Skin, Spinal Cord, Brain, Liver, Heart

Publications for Nerve Compression Syndrome

Articles related to Nerve Compression Syndrome:

(show top 50) (show all 128)
# Title Authors Year
1
Entrapment Neuropathies of the Upper Extremity. ( 30704687 )
2019
2
Entrapment Neuropathies of the Lower Extremity. ( 30704688 )
2019
3
Tumour-like giant nerves in entrapment neuropathies. ( 29353184 )
2018
4
Entrapment Neuropathies: Challenging Common Beliefs With Novel Evidence. ( 29385943 )
2018
5
Sensory profiles are comparable in patients with distal and proximal entrapment neuropathies, while the pain experience differs. ( 29526115 )
2018
6
Peripheral nerve injuries in the pediatric population: a review of the literature. Part II: entrapment neuropathies. ( 30209596 )
2018
7
MR Imaging of Entrapment Neuropathies of the Lower Extremity. ( 30322495 )
2018
8
Redo Microvascular Decompression in a Patient of Resistant Cochleovestibular Nerve Compression Syndrome. ( 29114297 )
2017
9
Carpal Tunnel Syndrome and Other Entrapment Neuropathies. ( 29218119 )
2017
10
Negative Neurodynamic Tests Do Not Exclude Neural Dysfunction in Patients With Entrapment Neuropathies. ( 27449322 )
2017
11
Common Entrapment Neuropathies. ( 28375915 )
2017
12
Cochleovestibular nerve compression syndrome due to intrameatal Anterior Inferior Cerebellar Artery loop: synthesis of best evidence for clinical decisions. ( 27647022 )
2016
13
Resolution of intractable retching following mobilization of a dolichoectatic vertebral artery: case report of a unique brainstem-cranial nerve compression syndrome. ( 27767394 )
2016
14
Uridine monophosphate, folic acid and vitamin B12 in patients with symptomatic peripheral entrapment neuropathies. ( 26679082 )
2016
15
Diagnostic accuracy of nerve ultrasound in hereditary and sporadic non-entrapment neuropathies. ( 27502085 )
2016
16
Entrapment neuropathies in diabetes mellitus. ( 27660694 )
2016
17
Electrodiagnostic approach in entrapment neuropathies of the median and ulnar nerves. ( 26150869 )
2015
18
Entrapment Neuropathies of the Foot and Ankle. ( 26409596 )
2015
19
Treatment of low back pain in patients with vertebral compression fractures and superior cluneal nerve entrapment neuropathies. ( 26693392 )
2015
20
Focal and entrapment neuropathies. ( 25410212 )
2014
21
Assessment of the utility of ultrasonography with high-frequency transducers in the diagnosis of entrapment neuropathies. ( 26674099 )
2014
22
Entrapment neuropathies of the lower extremity. ( 23542774 )
2013
23
Entrapment neuropathies. ( 23642716 )
2013
24
Neuromuscular ultrasound in common entrapment neuropathies. ( 23681885 )
2013
25
Compression and entrapment neuropathies. ( 23931789 )
2013
26
Reappraising entrapment neuropathies--mechanisms, diagnosis and management. ( 24008054 )
2013
27
Entrapment neuropathies in chronic stroke patients. ( 22353993 )
2012
28
Entrapment neuropathies of the shoulder. ( 22469409 )
2012
29
Entrapment neuropathies in the upper and lower limbs: anatomy and MRI features. ( 23125929 )
2012
30
Electrophysciological analysis of entrapment neuropathies developed in acute and subacute period in paretic and non-paretic extremities in patients with stroke. ( 23866507 )
2012
31
Ultrasound assessment of selected peripheral nerves pathologies. Part II: Entrapment neuropathies of the lower limb. ( 26673938 )
2012
32
Anterior interosseous nerve compression syndrome: is there a role for endoscopy? ( 21786008 )
2011
33
Hypertrophic abductor hallucis muscle with nerve compression syndrome. ( 21381535 )
2010
34
Entrapment neuropathies II: carpal tunnel syndrome. ( 21072727 )
2010
35
A commentary on the relation between putative central plastic changes and sensory symptoms in peripheral entrapment neuropathies. ( 20403665 )
2010
36
MR imaging of entrapment neuropathies of the lower extremity. Part 1. The pelvis and hip. ( 20631364 )
2010
37
MR imaging of entrapment neuropathies of the lower extremity. Part 2. The knee, leg, ankle, and foot. ( 20631365 )
2010
38
What's new in the diagnosis and treatment of peripheral nerve entrapment neuropathies. ( 20816274 )
2010
39
Entrapment neuropathies I: upper limb (carpal tunnel excluded). ( 21072726 )
2010
40
Entrapment neuropathies III: lower limb. ( 21072728 )
2010
41
Impaired laryngeal mobility and entrapment neuropathies. ( 21077411 )
2010
42
Invited commentary. Carpal tunnel syndrome is one of the most common peripheral entrapment neuropathies and is associated with substantial direct medical costs and with economic costs in terms of man day loss and possible continuing disability. ( 19777684 )
2009
43
Clinical relevance of neuromuscular findings and abnormal movement patterns: a comparison between focal hand dystonia and upper extremity entrapment neuropathies. ( 19278824 )
2009
44
Development of entrapment neuropathies in acute stroke patients. ( 19053953 )
2009
45
Prevalence and risk factors for upper extremity entrapment neuropathies in polio survivors. ( 19197565 )
2009
46
Macrodystrophia lipomatosa with multiple entrapment neuropathies: a case report. ( 18322862 )
2008
47
What's new in common upper extremity entrapment neuropathies. ( 19010282 )
2008
48
Controversial entrapment neuropathies. ( 19010284 )
2008
49
Differential diagnosis of cervical nerve compression syndrome of the external intervertebral foramen. ( 24557672 )
2007
50
Diagnosing entrapment neuropathies: probes and magnets instead of electrodes and needles? ( 16368263 )
2006

Variations for Nerve Compression Syndrome

Expression for Nerve Compression Syndrome

Search GEO for disease gene expression data for Nerve Compression Syndrome.

Pathways for Nerve Compression Syndrome

GO Terms for Nerve Compression Syndrome

Sources for Nerve Compression Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....